Advanced search
1 file | 553.74 KB

Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1

(2011) CYTOKINE & GROWTH FACTOR REVIEWS. 22(5-6). p.311-319
Author
Organization
Keywords
TUMOR-NECROSIS-FACTOR, Adverse effects, Therapy, Autoimmunity, TNF, COLLAGEN-INDUCED ARTHRITIS, REGULATORY T-CELLS, FACTOR-ALPHA THERAPY, ANTAGONISTIC MUTANT TNF, INDUCED LIVER-INJURY, FACTOR-RECEPTOR, RHEUMATOID-ARTHRITIS, DEFICIENT MICE, IMMUNE-SYSTEM

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 553.74 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Van Hauwermeiren, Filip, Roosmarijn Vandenbroucke, and Claude Libert. 2011. “Treatment of TNF Mediated Diseases by Selective Inhibition of Soluble TNF or TNFR1.” Cytokine & Growth Factor Reviews 22 (5-6): 311–319.
APA
Van Hauwermeiren, F., Vandenbroucke, R., & Libert, C. (2011). Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1. CYTOKINE & GROWTH FACTOR REVIEWS, 22(5-6), 311–319.
Vancouver
1.
Van Hauwermeiren F, Vandenbroucke R, Libert C. Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1. CYTOKINE & GROWTH FACTOR REVIEWS. 2011;22(5-6):311–9.
MLA
Van Hauwermeiren, Filip, Roosmarijn Vandenbroucke, and Claude Libert. “Treatment of TNF Mediated Diseases by Selective Inhibition of Soluble TNF or TNFR1.” CYTOKINE & GROWTH FACTOR REVIEWS 22.5-6 (2011): 311–319. Print.
@article{2004158,
  author       = {Van Hauwermeiren, Filip and Vandenbroucke, Roosmarijn and Libert, Claude},
  issn         = {1359-6101},
  journal      = {CYTOKINE \& GROWTH FACTOR REVIEWS},
  language     = {eng},
  number       = {5-6},
  pages        = {311--319},
  title        = {Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1},
  url          = {http://dx.doi.org/10.1016/j.cytogfr.2011.09.004},
  volume       = {22},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: